Photochemical and thermal hydrogen production from water catalyzed by carboxylate-bridged dirhodium(II) complexes.

Dalton Trans

Department of Chemistry, Faculty of Science, Kyushu University, Hakozaki, Higashi-ku, Fukuoka 812-8581, Japan.

Published: December 2010

A series of dinuclear Rh(II) complexes, [Rh(2)(μ-OAc)(4)(H(2)O)(2)] (HOAc = acetic acid) (1), [Rh(2)(μ-gly)(4)(H(2)O)(2)] (Hgly = glycolic acid) (2), [Rh(2)(μ-CF(3)CO(2))(4)(acetone)(2)] (3), and [Rh(2)(bpy)(2)(μ-OAc)(2)(OAc)(2)] (4), were found to serve as H(2)-evolving catalysts in a three-component system consisting of tris(2,2'-bipyridine)ruthenium(II) (Ru(bpy)(3)(2+)), methylviologen (MV(2+)), and ethylenediaminetetraacetic acid disodium salt (EDTA). It was also confirmed that thermal reduction of water into H(2) by MV(+)˙, in situ generated by the bulk electrolysis of MV(2+), is effectively promoted by 1 as a H(2)-evolving catalyst. The absorption spectra of the photolysis solution during the photocatalysis were monitored up to 6 h to reveal that the formation of photochemical or thermal byproducts of MV(+)˙ is dramatically retarded in the presence of the Rh(II)(2) catalysts, for the H(2) formation rather than the decomposition of MV(+)˙ becomes predominant in the presence of the Rh(II)(2) catalysts. The stability of the Rh(II)(2) dimers was confirmed by absorption spectroscopy, (1)H NMR, and ESI-TOF mass spectroscopy. The results indicated that neither elimination nor replacement of the equatorial ligands take place during the photolysis, revealing that one of the axial sites of the Rh(2) core is responsible for the hydrogenic activation. The quenching of Ru*(bpy)(3)(2+) by 1 was also investigated by luminescence spectroscopy. The rate of H(2) evolution was found to decrease upon increasing the concentration of 1, indicating that the quenching of Ru*(bpy)(3)(2+) by the Rh(ii)(2) species rather than by MV(2+) becomes predominant at the higher concentrations of 1. The DFT calculations were carried out for several possible reaction paths proposed (e.g., [Rh(II)(2)(μ-OAc)(4)(H(2)O)] + H(+) and [Rh(II)(2)(μ-OAc)(4)(H(2)O)] + H(+) + e(-)). It is suggested that the initial step is a proton-coupled electron transfer (PCET) to the Rh(II)(2) dimer leading to the formation of a Rh(II)Rh(III)-H intermediate. The H(2) evolution step is suggested to proceed either via the transfer of another set of H(+) and e(-) to the Rh(II)Rh(III)-H intermediate or via the homolytic radical coupling through the interaction of two Rh(II)Rh(III)-H intermediates.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c0dt00741bDOI Listing

Publication Analysis

Top Keywords

photochemical thermal
8
presence rhii2
8
rhii2 catalysts
8
quenching ru*bpy32+
8
rhiirhiii-h intermediate
8
rhii2
5
thermal hydrogen
4
hydrogen production
4
production water
4
water catalyzed
4

Similar Publications

Antimicrobial photodynamic therapy (aPDT) utilizes light-sensitive materials to inactivate pathogens. Indocyanine green (ICG) is an FDA-approved photosensitizer known for its effective photo-thermal and photo-chemical properties.

View Article and Find Full Text PDF

Biomedical Application Prospects of Gadolinium Oxide Nanoparticles for Regenerative Medicine.

Pharmaceutics

December 2024

Department of Hospital Surgery, Department of Plastic and Reconstructive Surgery, Cosmetology and Cell Technology, Pirogov Russian National Research Medical University (RNRMU), 117997 Moscow, Russia.

Background/objectives: The aim was to study the possibilities of biomedical application of gadolinium oxide nanoparticles (GdO NPs) synthesized under industrial conditions, and evaluate their physicochemical properties, redox activity, biological activity, and safety using different human cell lines.

Methods: The powder of GdO NPs was obtained by a process of thermal decomposition of gadolinium carbonate precipitated from nitrate solution, and was studied using transmission electron microscopy (TEM), X-ray diffraction (XRD), Raman spectroscopy, mass spectrometry, and scanning electron microscopy (SEM) with energy dispersive X-ray analyzer (EDX). The redox activity of different concentrations of GdO NPs was studied by the optical spectroscopy (OS) method in the photochemical degradation process of methylene blue dye upon irradiation with an optical source.

View Article and Find Full Text PDF

Mass Spectrometry-Based Protein Footprinting for Protein Structure Characterization.

Acc Chem Res

January 2025

Department of Chemistry, Washington University, St. Louis, Missouri 63130, United States.

ConspectusProtein higher-order structure (HOS) is key to biological function because the mechanisms of protein machinery are encoded in protein three-dimensional structures. Mass spectrometry (MS)-based protein footprinting is advancing protein structure characterization by mapping solvent-accessible regions of proteins and changes in H-bonding, thereby providing higher order structural information. Footprinting provides insights into protein dynamics, conformational changes, and interactions, and when conducted in a differential way, can readily reveal those regions that undergo conformational change in response to perturbations such as ligand binding, mutation, thermal stress, or aggregation.

View Article and Find Full Text PDF

Photochemical Deracemization of 4,7-Diaza-1-isoindolinones by Unidirectional Hydrogen Atom Shuttling.

J Am Chem Soc

December 2024

School of Natural Sciences, Department Chemie, and Catalysis Research Center (CRC), Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany.

By coupling a photochemical and a thermal step, a single chiral catalyst can establish a photostationary state in which the enantiopure form of a chiral compound is favored over its racemate. Following this strategy, 3-substituted 4,7-diaza-1-isoindolones were successfully deracemized (74-98% yield, 86-99% ) employing 2.5 mol % of a photocatalyst.

View Article and Find Full Text PDF

Photoswitchable Diazocine Derivative for Adenosine A Receptor Activation in Psoriasis.

J Am Chem Soc

January 2025

Pharmacology Unit, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, L'Hospitalet de Llobregat 08907, Spain.

Incorporating photoisomerizable moieties within drugs offers the possibility of rapid and reversible light-dependent switching between active and inactive configurations. Here, we developed a photoswitchable adenosine A receptor (AR) agonist that confers optical control on this G protein-coupled receptor through noninvasive topical skin irradiation in an animal model of psoriasis. This was achieved by covalently bonding an adenosine-5'-methyluronamide moiety to a diazocine photochrome, whose singular photoswitching properties facilitated repeated interconversion between a thermally stable, biologically inactive agonist form and a photoinduced, pharmacologically active configuration.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!